ATE126700T1 - Verbesserte therapiemethode. - Google Patents

Verbesserte therapiemethode.

Info

Publication number
ATE126700T1
ATE126700T1 AT91308457T AT91308457T ATE126700T1 AT E126700 T1 ATE126700 T1 AT E126700T1 AT 91308457 T AT91308457 T AT 91308457T AT 91308457 T AT91308457 T AT 91308457T AT E126700 T1 ATE126700 T1 AT E126700T1
Authority
AT
Austria
Prior art keywords
agent
therapy method
improved therapy
antifolate
inhibitor
Prior art date
Application number
AT91308457T
Other languages
English (en)
Inventor
Gerald Burr Grindey
Shih Chuan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24717023&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE126700(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE126700T1 publication Critical patent/ATE126700T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT91308457T 1991-03-29 1991-09-17 Verbesserte therapiemethode. ATE126700T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67703191A 1991-03-29 1991-03-29

Publications (1)

Publication Number Publication Date
ATE126700T1 true ATE126700T1 (de) 1995-09-15

Family

ID=24717023

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91308457T ATE126700T1 (de) 1991-03-29 1991-09-17 Verbesserte therapiemethode.

Country Status (12)

Country Link
EP (1) EP0505640B2 (de)
JP (1) JP3468534B2 (de)
AT (1) ATE126700T1 (de)
AU (1) AU640524B2 (de)
CA (1) CA2051520C (de)
CY (1) CY1888A (de)
DE (1) DE69112376T3 (de)
DK (1) DK0505640T4 (de)
ES (1) ES2077808T5 (de)
GR (1) GR3017774T3 (de)
HK (1) HK161495A (de)
ZA (1) ZA917406B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226842D0 (en) 1992-12-23 1993-02-17 Wellcome Found Pharmaceutical compounds
WO2002002093A2 (en) * 2000-06-30 2002-01-10 Eli Lilly And Company Combination containing an antifolate and methylmalonic acid lowering agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2688018A (en) 1952-06-28 1954-08-31 American Cyanamid Co Method of preparing alkaline earth metal salts of 1-leucovorin
US4931441A (en) † 1988-11-09 1990-06-05 Luitpold Pharmaceuticals, Inc. Stabilized aqueous leucovorin calcium compositions
US4999424A (en) * 1988-11-10 1991-03-12 The Pennsylvania State University GAR transformylase inhibitor
CH676981A5 (de) † 1988-11-11 1991-03-28 Eprova Ag
US5008391A (en) * 1989-07-07 1991-04-16 Eli Lilly And Company Enantioselective synthesis of antifolates

Also Published As

Publication number Publication date
ZA917406B (en) 1993-03-17
CA2051520A1 (en) 1992-09-30
CA2051520C (en) 2003-02-18
DK0505640T4 (da) 2002-12-16
EP0505640B1 (de) 1995-08-23
DE69112376T2 (de) 1996-03-14
JP3468534B2 (ja) 2003-11-17
DK0505640T3 (da) 1995-12-27
ES2077808T3 (es) 1995-12-01
EP0505640A1 (de) 1992-09-30
HK161495A (en) 1995-10-20
GR3017774T3 (en) 1996-01-31
AU640524B2 (en) 1993-08-26
CY1888A (en) 1996-04-05
AU8457091A (en) 1992-10-01
DE69112376T3 (de) 2002-08-14
JPH0597705A (ja) 1993-04-20
DE69112376D1 (de) 1995-09-28
EP0505640B2 (de) 2002-02-27
ES2077808T5 (es) 2002-10-16

Similar Documents

Publication Publication Date Title
NO942283L (no) Pyrofeoforbider og deres anvendelse i fotodynamisk terapi
FI955911A7 (fi) Pyratsolopyrimidinonit impotenssin hoidossa
BR9406990A (pt) Corpo e artigo absorventes
NO992373L (no) Forlenget anestesi i ledd og kroppshulrom
FI944600A7 (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
FI924661L (fi) Inhalaatiolaitteen yhteydessä käytettävä venttiili
FI940375L (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
DK0679717T3 (da) Opløselig interferon-receptor og fremstilling og anvendelse heraf
GB9103075D0 (en) Trinitrobenzene derivatives and their therapeutic use
DE69112376D1 (de) Verbesserte Therapiemethode.
FI940186A7 (fi) 9H-imidatso/1,2-a/bentsimidatsoli-3-asetamidijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
ATA147691A (de) Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung
ZA932761B (en) Diamine derivatives and application thereof in therapeutic fields
IS1880B (is) Nýtt skömmtunarform hýdroxókóbalamíns og notkun þess við sýaníðeitrunum
FI961339A7 (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
ZA92357B (en) Amide derivatives and their therapeutic use.
KR950701812A (ko) 렌티바이러스-유도된 질환의 치료에 유용한 생물학적으로 활성인 우레이도 유도체(Biologically active ureido dervatives useful in the treatment of lentivirus-induced sisease)
NO175398C (no) Ventillegeme og kuleventil
FI940185A7 (fi) 4-pyrimidinonijohdannaisten suoloja, niiden valmistus ja niiden käyttö terapiassa
FI933386A7 (fi) Pienimolekyylisiä sulfatoituja poly-b-2,6-fruktofuranosaaneja ja niide n käyttö rappeuttavien nivelsairauksien hoitoon
DK0872238T3 (da) Anvendelse af olanzapin til fremstilling af et medikament til neuroprotektin
KR950013360U (ko) 지압 및 쑥뜸을 겸용되게한 원형지압구
YU40098A (sh) Upotreba olanzapina za dobijanje leka
BR7301816U (pt) Bola mágica
ITFI920241A0 (it) Impiego della melatonina nella terapia della sclerosi sistematica, della sarcoidosi ed altro

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification

Ref document number: 0505640

Country of ref document: EP

REN Ceased due to non-payment of the annual fee